Patent ID: 11865109
Assignee: NOVARTIS AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 4:
5. A process for the manufacture of the pharmaceutical composition according to claim 1 comprising the steps of: (a) blending (S)-3-amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide or a pharmaceutically acceptable salt, polymorph or co-crystal thereof together with sodium starch glycolate and optionally at least one pharmaceutically acceptable carrier to form a material, (b) wet milling the material to form a plurality of granules, (c) blending the granules with sodium stearyl fumarate and sodium starch glycolate and optionally at least one pharmaceutically acceptable carrier to form a final blend, and (d) compressing the final blend into a tablet.